Skip to main content
Premium Trial:

Request an Annual Quote

Focus Tech Claims First RT-PCR SARS Diagnostic

NEW YORK, May 5 - Focus Technologies said today that it has developed a first-generation real-time PCR test to detect the presence of the coronavirus associated with severe acute respiratory syndrome (SARS).

 

The company said its reference laboratory in Cypress, Calif., has begun performing SARS-associated coronavirus testing to help clinicians diagnose disease in suspected patients.

 

The test identifies genomic RNA from the coronavirus associated with SARS via reverse transcription of specific viral genomic RNA sequences followed by PCR amplification. The assay is based on previous work by World Health Organization and the Bernhard-Nocht Institute of Hamburg, Germany, to identify PCR primers for the virus.

 

Focus Technologies said it also offers viral culture test methods capable of growing the SARS coronavirus.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.